INTRODUCTION
Laparoscopic cholecystectomy is known to be associated with considerable postoperative pain. 1 Alleviation of postoperative pain can be attempted by using battery of pharmacological agents ranging from NSAIDs to steroids to narcotics. Nevertheless, this attempt is often frustrating in case of postoperative nausea and vomiting. This has aptly been described as the "big little problem" by Kapur in an editorial review.
For better management of postoperative pain, nausea and vomiting, it is important to appreciate the physiological process involved in pain initiation, propagation and response. There are visceral and somatic components of pain, further compounded by CO₂ used for peritoneal insufflation. Post-operative nausea-vomiting and pain constitute a vicious cycle which may aggravate each other. This concept of 'visceral nociception' as a significant source of post-operative morbidity needs to be addressed to further improve patient's experience after laparoscopic cholecystectomy.
In order to address the issue of 'visceral nociception' as a significant source of these post-operative morbidity, the idea of intraperitoneal local anesthetic (IPLA) instillation was promulgated. Thus, as the search for improving postoperative outcomes continues, this study was designed and conducted with a humble attempt to evaluate the efficacy of intra-peritoneal lignocaine instillation, and its timing, as an adjunct to reduce post-operative morbidities.
METHODS

Patients
The minimum required sample size was calculated using data of previous study conducted by Razek Numbers allotted to bottles were computer generated password protected random numbers. These were marked by third person and the content of bottles were disclosed only at the end of the study after all data collection had completed. These two sets of bottles (40 each) were kept in two separate autoclaved drums. A computer generated random list of pre/post was created (40 each). Patients were instilled according to the list and bottles were picked from pre-dissection set and post-dissection set accordingly without having knowledge regarding the content of the vial.
Randomization and double blinding
Distribution of patients in the groups in terms of Age, Gender, BMI, Co-morbidity (DM and HTN) was not significantly different. Distribution of operative parameters of the patients in the groups in terms of adhesion, bile spillage, mean duration of surgery and no of ports were not significantly different.
Data recording
Drug instillation
• Code labelled bottle.
• Contents of the bottle were revealed by decoding after completion of study and collection of all data
Intra-operative parameters
Adhesions, bile or stone spillage, any injury to extra hepatic biliary system including the arteries and veins and any injury to regional arteries and vein.
Post-operative parameters (at 1, 2, 4, 6, 12 and 24hours)
• Pain (VAS Scale)
• Nausea-Vomiting • Pulse Rate, Blood Pressure, Respiratory Rate • Rescue analgesia • Day of discharge
Statistical analysis
The relation between qualitative variables was assessed by chi square test. Student t-test was used for difference between means of different data arrays paired or unpaired two-tailed Student's t-test was employed, depending on the circumstance. ANOVA test was used to compare three or more means was used to compare percentage of paired data. The quantitative variables were summarized as mean and 95% Confidence Interval (CI).
RESULTS
Pain
Post-operative pain was measured in terms of the VAS score. The score was less in lignocaine group. The difference was statistically significant (p<0.05) at 1 hr, 2hr, 4 hr, 6 hr, 12 hr and 24 hr between lignocaine group and placebo Group. On the other hand, there was no statistically significant difference between the mean of VAS scores of pre-dissections lignocaine and postdissection lignocaine subgroups. Although the post-operative pain perception was significantly higher in females as compared to males, females seems to benefit more than males by intraperitoneal lignocaine instillation. Difference was not statistically significant. In context with age, pain perception showed declining trend with advancing age in both the groups.
VAS(1hr) VAS(2hr) VAS(4hr) VAS(6hr) VAS(12hr) VAS(24hr)
Patients having intra-operative adhesion seems to have lesser post-operative pain in both the groups. On the other hand, no relation could be established with other factors like bile spillage, stone spillage and duration of surgery.
Post-operative analgesia
In lignocaine group, 27.8%, 75%, 41% and 25% of the subject required rescue analgesia in 1sthr, next 1-8 hr, 
Post-operative nausea and vomiting
Post operatively nausea perception, seemed to be slightly higher in placebo group as compared to lignocaine group but difference was statistically insignificant (p>0.05). Incidence of post-operative nausea was negligible after 4th post-operative hour. There was no significant difference (p >0.05) in post-operative vomiting between placebo and lignocaine group. The subgroup statistical analysis showed similar results.
Post-operative vitals
Post-operative pulse rate was lower in the patients receiving intraperitoneal lignocaine instillation as compare to patients of placebo group It was significantly different (p<0.05) at 1 st hr and 12 th hr between lignocaine group and placebo group. The subgroups pre-dissection lignocaine and post-dissection lignocaine, showed no statistically significant difference in post-operative pulse rate (p>0.05). However other parameters including mean arterial pressure, respiratory rate and SpO2 were similar in both groups.
Adverse events
No adverse reaction to lignocaine has been reported in any of the patients included in the study.
Day of discharge
Patients of lignocaine group had significantly shorter duration of hospital stay as compared to placebo group. While no difference observed between the subgroups; pre-dissection lignocaine and post dissection lignocaine group (p >0.05). 
DISCUSSION
The pain after laparoscopic cholecystectomy is multifactorial and can be because of the one arising from incision sites (somatic pain), from the gallbladder bed (visceral pain) and as a consequence of capnoperitoneum.
It is therefore likely that combined methods of analgesia can best reduce the post-operative pain. 4 Four main types of visceral stimuli (electrical, mechanical, ischemic and chemical) have been employed in experimental studies on visceral nociception. 
Day 1 Day 2 Day 3
The available evidence indicates that these two classes of visceral extrinsic nerves (vagal and spinal) exhibit a number of contrasting properties, which in turn reflect their diverse role in sensory signaling. An enormous range of chemical mediators have been implicated in sensory signal transduction in the viscera.
Local anesthetics directly interact with voltage-gated Na + channels and block conduction by decreasing or preventing the large transient increase in the permeability of excitable membranes to Na + that normally is produced by a slight depolarization of the membrane. 6 Considering the important role of sodium channels in pain pathway and the effectiveness of local anaesthesia in blocking them, it's obvious that local anaesthesia can be utilized to alleviate post-operative pain. Direct application of local anaesthesia to the site of surgical dissection seems a prudent appropriate in this respect.
LAs have well known anti-inflammatory actions. Animal work on IPLA has been interesting and showed lignocaine and bupivacaine prevented peritonitis and adhesion formation. Eutectic mixture of local anaesthetics (EMLA-lignocaine/procaine) inhibited the adhesion formation after bacterial peritonitis in rats compared with controls. 7, 8 Lignocaine applied to obstructed bowel serosa, inhibited and reversed gut fluid losses and inflammation. 9 To the knowledge, these benefits have not been shown clinically.
The mechanism of action of IPLA is not fully understood, although it is likely that there is blockade of free afferent nerve endings in the peritoneum. Systemic absorption of LA from the peritoneal cavity may also play some part in reduced nociception.
The peritoneum cavity is the largest serous membrane in the body and has a surface area of 1.8m 2 , close to that of the skin. 10 It is known that systemic levels of LA are detectable in the serum circulation as soon as 2 minutes after bolus instillation into the peritoneum, reaching a systemic maximum after 10-30 min. 
